- Home
- RSSS vs ONCY Comparison
RSSS vs ONCY Comparison
Compare RSSS & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- ONCY
- Stock Information
- Founded
- RSSS 2006
- ONCY 1998
- Country
- RSSS United States
- ONCY Canada
- Employees
- RSSS N/A
- ONCY N/A
- Industry
- RSSS Business Services
- ONCY Pharmaceuticals and Biotechnology
- Sector
- RSSS Consumer Discretionary
- ONCY Health Care
- Exchange
- RSSS Nasdaq
- ONCY Nasdaq
- Market Cap
- RSSS 110.0M
- ONCY 89.7M
- IPO Year
- RSSS N/A
- ONCY 1999
- Fundamental
- Price
- RSSS $3.24
- ONCY $1.19
- Analyst Decision
- RSSS Strong Buy
- ONCY Strong Buy
- Analyst Count
- RSSS 1
- ONCY 5
- Target Price
- RSSS $5.00
- ONCY $5.00
- AVG Volume (30 Days)
- RSSS 71.1K
- ONCY 900.3K
- Earning Date
- RSSS 11-13-2025
- ONCY 11-07-2025
- Dividend Yield
- RSSS N/A
- ONCY N/A
- EPS Growth
- RSSS N/A
- ONCY N/A
- EPS
- RSSS 0.04
- ONCY N/A
- Revenue
- RSSS $49,057,981.00
- ONCY N/A
- Revenue This Year
- RSSS $5.79
- ONCY N/A
- Revenue Next Year
- RSSS $8.46
- ONCY N/A
- P/E Ratio
- RSSS $81.00
- ONCY N/A
- Revenue Growth
- RSSS 9.94
- ONCY N/A
- 52 Week Low
- RSSS $2.32
- ONCY $0.33
- 52 Week High
- RSSS $4.24
- ONCY $1.51
- Technical
- Relative Strength Index (RSI)
- RSSS 43.66
- ONCY 47.77
- Support Level
- RSSS $3.21
- ONCY $1.16
- Resistance Level
- RSSS $3.46
- ONCY $1.32
- Average True Range (ATR)
- RSSS 0.12
- ONCY 0.07
- MACD
- RSSS -0.01
- ONCY -0.00
- Stochastic Oscillator
- RSSS 30.22
- ONCY 42.22
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from its cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.